Qualigen Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.55 Insider Own0.10% Shs Outstand35.29M Perf Week-7.53%
Market Cap18.97M Forward P/E- EPS next Y-0.62 Insider Trans165.06% Shs Float31.18M Perf Month-6.79%
Income-17.00M PEG- EPS next Q-0.16 Inst Own8.30% Short Float4.61% Perf Quarter-20.91%
Sales4.50M P/S4.22 EPS this Y45.60% Inst Trans4.94% Short Ratio1.23 Perf Half Y-54.61%
Book/sh0.38 P/B1.37 EPS next Y4.60% ROA-87.20% Target Price5.75 Perf Year-73.64%
Cash/sh0.37 P/C1.40 EPS next 5Y- ROE-127.70% 52W Range0.45 - 3.12 Perf YTD-51.21%
Dividend- P/FCF- EPS past 5Y65.40% ROI-136.60% 52W High-83.27% Beta-0.48
Dividend %- Quick Ratio4.20 Sales past 5Y- Gross Margin11.60% 52W Low16.00% ATR0.05
Employees39 Current Ratio4.60 Sales Q/Q-63.20% Oper. Margin- RSI (14)40.26 Volatility7.10% 8.86%
OptionableYes Debt/Eq0.00 EPS Q/Q34.20% Profit Margin- Rel Volume0.16 Prev Close0.57
ShortableYes LT Debt/Eq0.00 EarningsMay 13 BMO Payout- Avg Volume1.16M Price0.52
Recom2.00 SMA20-10.16% SMA50-6.98% SMA200-41.53% Volume191,061 Change-8.37%
Jun-14-22 09:00AM  
Jun-07-22 09:04AM  
Jun-06-22 06:10AM  
Jun-02-22 09:00AM  
May-26-22 09:15AM  
May-20-22 09:15AM  
May-13-22 06:00AM  
May-10-22 09:17AM  
May-03-22 02:24PM  
Apr-29-22 09:15AM  
Apr-18-22 06:25AM  
Apr-12-22 10:15AM  
Apr-05-22 09:15AM  
Apr-01-22 08:00AM  
Mar-30-22 09:15AM  
Mar-22-22 09:15AM  
Mar-15-22 09:15AM  
Feb-22-22 09:15AM  
Feb-15-22 09:15AM  
Feb-01-22 09:15AM  
Jan-18-22 09:15AM  
Dec-14-21 09:18AM  
Dec-01-21 03:25PM  
Nov-29-21 03:50PM  
Nov-22-21 10:23AM  
Nov-15-21 09:00AM  
Oct-19-21 09:00AM  
Sep-15-21 07:30AM  
Sep-08-21 07:30AM  
Aug-31-21 06:22AM  
Aug-23-21 09:58AM  
Aug-17-21 10:01AM  
Jul-14-21 07:30AM  
Jul-07-21 10:37AM  
Jun-08-21 07:30AM  
Jun-02-21 07:30AM  
May-19-21 07:30AM  
May-18-21 02:10PM  
May-14-21 01:35PM  
Apr-26-21 07:00AM  
Apr-19-21 01:16PM  
Apr-06-21 09:30AM  
Mar-18-21 08:30AM  
Mar-09-21 08:30AM  
Mar-08-21 08:30AM  
Mar-01-21 08:30AM  
Jan-26-21 09:00AM  
Dec-30-20 11:16AM  
Dec-22-20 09:00AM  
Dec-18-20 03:07PM  
Dec-16-20 10:25AM  
Dec-15-20 09:00AM  
Dec-08-20 09:00AM  
Dec-02-20 09:00AM  
Nov-30-20 09:40AM  
Nov-13-20 09:00AM  
Nov-05-20 09:00AM  
Oct-28-20 09:00AM  
Oct-08-20 09:00AM  
Oct-01-20 09:00AM  
Sep-21-20 11:53AM  
Sep-17-20 09:00AM  
Aug-31-20 09:00AM  
Aug-28-20 08:00AM  
Aug-20-20 08:00AM  
Aug-14-20 05:24PM  
Aug-06-20 03:59PM  
Aug-04-20 04:05PM  
Aug-02-20 05:32PM  
Jul-30-20 08:00AM  
Jul-22-20 08:00AM  
Jul-13-20 08:00AM  
Jul-10-20 04:05PM  
Jul-08-20 05:19PM  
Jul-07-20 08:00AM  
Jul-01-20 08:00AM  
Jun-10-20 08:00AM  
Jun-04-20 08:00AM  
Jun-02-20 08:00AM  
May-26-20 07:00AM  
Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Poirier Michael S.Chairman and CEOJun 22Buy0.5730,00017,100199,202Jun 22 04:55 PM
BROIDRICK AMY S.President/CSOJun 14Buy0.6230,00018,60034,500Jun 15 04:05 PM
Kruger Kurt HDirectorAug 19Buy1.238,0009,80018,000Aug 20 03:05 PM